Studies of AML patients show that many cases (~35%) have mutations in type III receptor tyrosine kinase FLT3 and that HOXB2 and HOXB3 are increased in AML patients with FTL3-ITD (internal tandem duplication) mutation. Here, HOXB2 is linked to acute myeloid leukemia.